Literature DB >> 12401726

No association between lck gene polymorphisms and protein level in type 1 diabetes.

Solange Nervi1, Sandra Nicodeme, Corinne Gartioux, Catherine Atlan, Marc Lathrop, Denis Reviron, Philippe Naquet, Fumihiko Matsuda, Jean Imbert, Bernard Vialettes.   

Abstract

We previously described a reduced expression of the protein tyrosine kinase Lck in T-cells from type 1 diabetic patients, the origin of which is still unknown. The human lck gene, located on chromosome 1p35-34.3, was evaluated as a candidate susceptibility gene for type 1 diabetes. A molecular scan of the sequence variations in the coding, the relevant promoter, and most of the intronic sequences of the lck gene (representing a total of 10.5 kb fragment) was performed in 187 Caucasian subjects including 91 type 1 diabetic patients and 96 normoglycemic control subjects. We identified 35 sequence variations, including one deletion and 34 single nucleotide polymorphisms (SNPs), 33 of them being new. Four variants were frequent but not significantly associated with diabetes or Lck protein level. Of the SNP variants, 11 were only found within the diabetic population and some were associated with low Lck protein levels. The low frequency of these polymorphisms did not permit any statistically significant correlations with the disease status, suggesting that the lck gene probably does not contribute to genetic susceptibility to type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401726     DOI: 10.2337/diabetes.51.11.3326

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  2 in total

1.  Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms.

Authors:  Peng Gao; Yan Jiao; Qing Xiong; Cong-Yi Wang; Ivan Gerling; Weikuan Gu
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

2.  Ex vivo induction of mRNA in human whole blood as a new platform of drug and dietary supplement development.

Authors:  Masato Mitsuhashi; Mieko Ogura; Katsuya Endo; Kazuhiko Obara; Hiroshi Izutsu; Stephan R Targan; Motoko Maemura; Daisuke Tachikawa; Atsushi Shinagawa
Journal:  Pharm Res       Date:  2008-01-09       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.